Feb 15 |
Alkermes' (ALKS) Q4 Earnings & Revenues Surpass Estimates
|
Feb 15 |
Compared to Estimates, Alkermes (ALKS) Q4 Earnings: A Look at Key Metrics
|
Feb 15 |
Alkermes PLC (ALKS) Reports Strong 2023 Financial Results and Sets Positive Outlook for 2024
|
Feb 15 |
Alkermes Non-GAAP EPS of $0.22 misses by $0.24, revenue of $377.5M beats by $15.13M
|
Feb 15 |
Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2023 and Provides Financial Expectations for 2024
|
Feb 15 |
Is Alkermes plc's (NASDAQ:ALKS) Recent Stock Performance Tethered To Its Strong Fundamentals?
|
Feb 14 |
Alkermes Q4 2023 Earnings Preview
|
Feb 13 |
Halozyme Therapeutics (HALO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
|
Feb 12 |
Exploring Analyst Estimates for Alkermes (ALKS) Q4 Earnings, Beyond Revenue and EPS
|
Feb 8 |
7 Biotech Stocks Fighting America’s Deadliest Diseases
|